HC Sponsor LLC - 29 Dec 2021 Form 4 Insider Report for Hyperfine, Inc. (HYPR)

Role
10%+ Owner
Signature
/s/ Arthur Bruce Cohen, as Authorized Signatory for HC Sponsor LLC
Issuer symbol
HYPR
Transactions as of
29 Dec 2021
Net transactions value
+$1,359,255
Form type
4
Filing time
20 Dec 2022, 15:58:30 UTC
Previous filing
27 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HYPR Class A Common Stock Purchase $700,000 +100,000 +10% $7.00 1,100,000 29 Dec 2021 See Footnotes F1, F2
transaction HYPR Class A Common Stock Purchase $91,609 +13,677 +1.2% $6.70 1,113,677 10 Jan 2022 See Footnote F1, F3
transaction HYPR Class A Common Stock Purchase $19,599 +2,913 +0.26% $6.73 1,116,590 11 Jan 2022 See Footnote F1, F4
transaction HYPR Class A Common Stock Purchase $55,245 +8,410 +0.75% $6.57 1,125,000 12 Jan 2022 See Footnote F1, F5
transaction HYPR Class A Common Stock Purchase $112,550 +25,000 +2.2% $4.50 1,150,000 21 Jan 2022 See Footnote F1
transaction HYPR Class A Common Stock Purchase $292,465 +78,053 +6.8% $3.75 1,228,053 26 Jan 2022 See Footnote F1, F6
transaction HYPR Class A Common Stock Purchase $87,788 +21,947 +1.8% $4.00 1,250,000 03 Feb 2022 See Footnote F1
transaction HYPR Class A Common Stock Other $0 -5,534,000 -100% $0.000000* 0 16 Dec 2022 Direct F1, F7, F8
holding HYPR Class A Common Stock 5,534,000 29 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

HC Sponsor LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed by HC Sponsor LLC (the "Sponsor"). HealthCor Group, LLC ("HealthCor Group") shares voting and/or dispositive control over the securities held by the Sponsor. HealthCor Group is controlled by Messrs. Arthur B. Cohen and Joseph P. Healey. Accordingly, all of the shares held by Sponsor may be deemed to be beneficially held by Messrs Cohen and Healey. Each such reporting person disclaims beneficial ownership of all securities reported herein except to the extent of their respective pecuniary interest therein.
F2 Includes 1,000,000 shares previously reported as owned directly. These shares are held by affiliates of the Reporting Persons. HealthCor Group shares voting and/or dispositive control over these securities.
F3 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.676 to $6.75, inclusive. The reporting persons undertake to provide to the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4.
F4 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.724 to $6.75, inclusive.
F5 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.55 to $6.613, inclusive.
F6 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.731 to $3.75, inclusive.
F7 Sponsor distributed these shares to its members on a pro rata basis for no consideration.
F8 A fund controlled by HealthCor Group and Messrs. Cohen and Healey are each members of Sponsor and received 526,020, 781,226 and 781, 227 shares in the distribution. Those shares are now owned by such persons directly.